The endomyocardial biopsy showed amyloid deposition, specifically wild type transthyretrein protein deposition.
Amyloidosis is an infiltrative multisystem disease with the severity of specific organ involvement (including the heart) dependent on the precursor protein. [2] There are different types, but the case presented is that of the senile cardiac amyloidosis. Senile cardiac amyloidosis almost always affects men in their seventies as a slow progressive disease with only cardiac involvement. [3] The first signs of senile cardiac amyloidosis are usually leg swelling or shortness of breath, both due to congestive heart failure. [4] Therapy for senile cardiac amyloidosis is, at present, purely symptomatic relief.
Medications for heart failure, such as ACE-I, beta-blocker and diuretics are still the mainstay for treatment. Patients with senile cardiac amyloidosis however, not uncommonly progress to complete heart block, and permanent pacing becomes necessary. [5] Prompt referral to advanced heart failure physicians may improve quality of life and reduce readmissions due to heart failure exacerbations in such patients.
